Rational approaches to drug pricing and insurance coverage
Americans rank lowering prescription drug prices as a top policy priority. We focus on developing rational approaches to drug pricing and reimbursement that sustain innovation while ensuring patient access and affordability.
Learn About Our Work
The Challenge
With new drugs entering the market at record-breaking prices and costly gene and cell therapies in the pipeline, access and affordability are pressing concerns. But the current healthcare system allows for, and even encourages, the rise.
Explore the Challenge
Who We Are
We are a non-partisan, independent research group with extensive interdisciplinary expertise in medicine, policy, economics, finance, and social science tackling this drug pricing challenge.
Learn More About UsLearn how drug pricing works
Certain aspects of the payment and reimbursement processes in the U.S. distort incentives and negatively influence drug prices. Learn how through our tutorials.
Explore Our TutorialsOur Tools
See All Tools
Drug Abacus
How would you price a drug? This interactive tool takes more than 50 cancer drugs and lets you compare the company's price to one based on "value."
Use the ToolPolicy Tracker
The DPL Policy Tracker keeps tabs on federal policy proposals to address US drug pricing issues.
Use the ToolLouisiana Budget Allocator
There is no such thing as a free drug. The Louisiana Budget Allocator analyzes the budget impacts of paying for Hepatitis C treatment for Louisiana's Medicaid and uninsured recipients.
Use the Tool